Polymorphisms and Serum Level of Mannose-Binding Lectin: An Iranian Survey
Mannose-binding lectin (MBL) is a Ca⁺² -dependent collagenous lectin, that is produced by liver and mediates innate immune responses by opsonization of pathogens. The serum level of MBL varies widely among healthy individuals, ranging from 0.05 µg/ml (or lower) to over 5 µg/ml, mainly depending on genetic variation. This study has examined promoter and exon 1 of mbl2 genotype among 117 Iranian healthy blood donors. MBL Single Nucleotide Polymorphisms (SNPs) were genotyped using polymerase chain reaction (PCR), and serum levels of MBL were quantified using a double-antibody enzyme linked immunosorbent assay (ELISA). Results of this study showed that there are two promoter polymorphisms at -550 (H/L variants) and -221 (Y/X variants) positions, and three polymorphisms in exon 1 at codon 52 (D Allele), 54 (B Allele), and 57 (C Allele) in this population. B allele was significantly correlated with the lowest serum MBL level. Our results also showed that the most frequent genotype was HYA/LXA, and the genotype that associated with the highest serum level of MBL was HYA/HYA. The genotype that causes lowest MBL production in Iranian population was LYB/LXA. These results showed some differences compared to that of the other populations. To verify the originality of these differences we may need to extend the study to a larger samples of respective populations; meanwhile the importance of a new mutation, nucleotide 101 of MBL2 exon1, reported in the current study should be taken in considerations in terms of its possible pathobiological effects in following studies.
1. Lee SG, Yum JS, Moon HM, Kim HJ, Yang YJ, Kim HL, et al. Analysis of mannose-binding lectin 2 (MBL2) genotype and the serum protein levels in the Korean population. Mol Immunol 2005; 42(8):969-77.
2. Minchinton RM, Dean MM, Clark TR, Heatley S, Mullighan CG. Analysis of the Relationship Between Mannose-Binding Lectin (MBL) Genotype, MBL levels and Function in an Australian Blood Donor Population. Scand J Immunol 2002; 56(6):630-41.
3. Babovic-Vuksanovic D, Snow K, Ten RM. Mannose- binding lectin (MBL) deficiency variant alleles in a Midwestern population of the United States. Ann Allergy Asthma Immunol 1999; 82(2):134-8.
4. Wiertsema SP, Herpers BL, Veenhoven RH, Salimans MM, Ruven HJ, Sanders EA, et al. Functional polymorphisms in the mannan binding lectin 2 gene: Effect on MBL levels and otitis media. J Allergy Clin Immunol 2206; 117(6):1344-50.
5. Carroll MC. The complement system in regulation of adaptive immunity. Nat Immunol 2004; 5(10):981-6.
6. Petersen SV, Thiel S, Jensenius JC. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 2001; 38(2-3):133-49.
7. Selander B, Mårtensson U, Weintraub A, Holmström E, Matsushita M, Thiel S, et al. Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2. J Clin Invest 2006;116(5):1425-34.
8. Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence- specific primers. J Immunol Methods 2000; 241(1-2):33-42.
9. Turner MW. The Role of Mannose-Binding Lectin in Health and Disease. HK J Paediatr 2002; 7:134-142.
10. Chen J, Xu Z, Ou X, Wang M, Yang X, Li Q. Mannose- binding lectin polymorphisms and recurrent respiratory tract infection in Chinese children. Eur J Pediatr 2009;168(11):1305-13.
11. Worthley DL, Bardy PG, Mullighan CG. Mannose- binding lectin: biology and clinical implications. Intern Med J 2005; 35(9):548-55.
12. Zahedifard S, Rashidi E, ShamsS, Saghafi Sh, Fazlollahi MR, Talebzadeh A, et al. Mannan-binding lectin serum levels in 593 healthy Iranian children and adults. IJAAI 2014; 13(2):120-4.
|Issue||Vol 13, No 6 (2014)|
|Complement System Haplotype Innate immunity Mannose-binding lectin Polymorphisms Single Nucleotide Polymorphism (SNP)|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|